Nov 15, 2023 / 02:30PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
We'll go ahead and get started. Good afternoon, and welcome to the Jefferies 2023 London Healthcare Conference. I'm Brandon Couillard. I cover life science tools and diagnostics sector here at the firm. It is a great pleasure to have Exact Sciences back at the conference again this year. Joining us for this conversation, CEO, Kevin Conroy; as well as EVP of Human Resources, Sarah Condella.
Sarah, Kevin, thanks so much for being here.
Kevin T. Conroy - Exact Sciences Corporation - Chairman of The Board & CEO
Well, Brandon and Jefferies, thank you for having us. It's always one of our favorite conferences to attend, and we really look forward to the conversation.
Questions and Answers:
Brandon Couillard - Jefferies LLC, Research Division - Equity AnalystMaybe just to kick things off, Kevin, I mean, in the third quarter, very solid 23% organic growth. Cologuard up 30% on a 30% comp. You posted positive adjusted EBITDA, again, for